Many patients with cancer cite lack of energy as a significant barrier to healthy living with proper diet and exercise, but that is not the only obstacle they face.A survey of nearly 2,000 patients found physical limitations from cancer treatment, high…
Eye Condition Risk Elevated With Semaglutide, but Still Low
New VA database study is the latest to find a small but significant increased risk for nonarteritic anterior ischemic optic neuropathy. Medscape Medical News
The 15-20 National Hospital and GenSight Biologics Announce the First Treatments in the French Named Patient Early Access Program (AAC) for GS010/LUMEVOQ®
PARIS–(BUSINESS WIRE)–Regulatory News: The 15-20 National Hospital (l’Hôpital national des 15-20) in Paris and GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing i…
Epioxa epithelium-on cross-linking procedure now available in US
Editor’s note: This is a developing story. Please check back soon for updates.Epioxa, the first FDA-approved epithelium-on cross-linking procedure, is now commercially available, according to a press release from Glaukos.The topical therapy offers a st…
Ndemex aims to be ‘part of daily ocular hygiene routine’
ORLANDO — Ndemex, a formulation of tea tree oil designed to promote ocular hygiene, is now available.It can be used once daily to help “support good ocular health in the fight against blepharitis and other eyelid skin conditions,” Brent Jones, senior v…
In-office dry eye treatments: Tried, true and new
With the singular exception of punctal or canalicular occlusion, when we are talking about in-office dry eye disease treatments, we are talking about treating meibomian gland dysfunction and evaporative dry eye.For decades, meibomian gland dysfunction …